Mixed Results with ARNI Therapy for Post-MI Heart Failure Prevention

(MedPage Today) -- For heart attack survivors with left ventricular dysfunction, sacubitril/valsartan (Entresto) was no better than ramipril at reducing heart failure (HF) events in the strictest sense in the PARADISE-MI trial, but several signals...